About Us Services Careers FAQ Contact Us 0
Home Pharmaceuticals Eye Health Supplements Market Size, Trends, Analysis Forecast till 2029
Eye Health Supplements Market

Eye Health Supplements Market Size, Share & Trends Analysis Report By Supplement Category (Carotenoids, Antioxidants, Omega-3 Fatty acids, Coenzyme Q10, Flavonoids), By Therapeutic Targets (Age-related Macular Degeneration (AMD), Cataract, Dry Eye Syndrome, Inflammation), By Product Type (Tablets, Capsules, Powder, Softgels, Liquid), By End-User (Hospitals, Eye Care Clinics, Pharmacy) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRPH1258DR
Last Updated : June 23, 2023
Author : Straits Research
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Eye Health Supplements Market Introduction
    2. By Supplement Category
      1. Introduction
        1. Supplement Category By Value
      2. Carotenoids
        1. By Value
        2. Lutein
          1. Lutein By Value
        3. Zeaxanthin
          1. Zeaxanthin By Value
      3. Antioxidants
        1. By Value
      4. Omega-3 Fatty acids
        1. By Value
      5. Coenzyme Q10
        1. By Value
      6. Flavonoids
        1. By Value
    3. By Therapeutic Targets
      1. Introduction
        1. Therapeutic Targets By Value
      2. Age-related Macular Degeneration (AMD)
        1. By Value
      3. Cataract
        1. By Value
      4. Dry Eye Syndrome
        1. By Value
      5. Inflammation
        1. By Value
    4. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Tablets
        1. By Value
      3. Capsules
        1. By Value
      4. Powder
        1. By Value
      5. Softgels
        1. By Value
      6. Liquid
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Eye Care Clinics
        1. By Value
      4. Pharmacy
        1. By Value
    1. Introduction
    2. By Supplement Category
      1. Introduction
        1. Supplement Category By Value
      2. Carotenoids
        1. By Value
        2. Lutein
          1. Lutein By Value
        3. Zeaxanthin
          1. Zeaxanthin By Value
      3. Antioxidants
        1. By Value
      4. Omega-3 Fatty acids
        1. By Value
      5. Coenzyme Q10
        1. By Value
      6. Flavonoids
        1. By Value
    3. By Therapeutic Targets
      1. Introduction
        1. Therapeutic Targets By Value
      2. Age-related Macular Degeneration (AMD)
        1. By Value
      3. Cataract
        1. By Value
      4. Dry Eye Syndrome
        1. By Value
      5. Inflammation
        1. By Value
    4. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Tablets
        1. By Value
      3. Capsules
        1. By Value
      4. Powder
        1. By Value
      5. Softgels
        1. By Value
      6. Liquid
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Eye Care Clinics
        1. By Value
      4. Pharmacy
        1. By Value
    6. U.S.
      1. By Supplement Category
        1. Introduction
          1. Supplement Category By Value
        2. Carotenoids
          1. By Value
          2. Lutein
            1. Lutein By Value
          3. Zeaxanthin
            1. Zeaxanthin By Value
        3. Antioxidants
          1. By Value
        4. Omega-3 Fatty acids
          1. By Value
        5. Coenzyme Q10
          1. By Value
        6. Flavonoids
          1. By Value
      2. By Therapeutic Targets
        1. Introduction
          1. Therapeutic Targets By Value
        2. Age-related Macular Degeneration (AMD)
          1. By Value
        3. Cataract
          1. By Value
        4. Dry Eye Syndrome
          1. By Value
        5. Inflammation
          1. By Value
      3. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Tablets
          1. By Value
        3. Capsules
          1. By Value
        4. Powder
          1. By Value
        5. Softgels
          1. By Value
        6. Liquid
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Eye Care Clinics
          1. By Value
        4. Pharmacy
          1. By Value
    7. Canada
    1. Introduction
    2. By Supplement Category
      1. Introduction
        1. Supplement Category By Value
      2. Carotenoids
        1. By Value
        2. Lutein
          1. Lutein By Value
        3. Zeaxanthin
          1. Zeaxanthin By Value
      3. Antioxidants
        1. By Value
      4. Omega-3 Fatty acids
        1. By Value
      5. Coenzyme Q10
        1. By Value
      6. Flavonoids
        1. By Value
    3. By Therapeutic Targets
      1. Introduction
        1. Therapeutic Targets By Value
      2. Age-related Macular Degeneration (AMD)
        1. By Value
      3. Cataract
        1. By Value
      4. Dry Eye Syndrome
        1. By Value
      5. Inflammation
        1. By Value
    4. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Tablets
        1. By Value
      3. Capsules
        1. By Value
      4. Powder
        1. By Value
      5. Softgels
        1. By Value
      6. Liquid
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Eye Care Clinics
        1. By Value
      4. Pharmacy
        1. By Value
    6. U.K.
      1. By Supplement Category
        1. Introduction
          1. Supplement Category By Value
        2. Carotenoids
          1. By Value
          2. Lutein
            1. Lutein By Value
          3. Zeaxanthin
            1. Zeaxanthin By Value
        3. Antioxidants
          1. By Value
        4. Omega-3 Fatty acids
          1. By Value
        5. Coenzyme Q10
          1. By Value
        6. Flavonoids
          1. By Value
      2. By Therapeutic Targets
        1. Introduction
          1. Therapeutic Targets By Value
        2. Age-related Macular Degeneration (AMD)
          1. By Value
        3. Cataract
          1. By Value
        4. Dry Eye Syndrome
          1. By Value
        5. Inflammation
          1. By Value
      3. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Tablets
          1. By Value
        3. Capsules
          1. By Value
        4. Powder
          1. By Value
        5. Softgels
          1. By Value
        6. Liquid
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Eye Care Clinics
          1. By Value
        4. Pharmacy
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europe
    1. Introduction
    2. By Supplement Category
      1. Introduction
        1. Supplement Category By Value
      2. Carotenoids
        1. By Value
        2. Lutein
          1. Lutein By Value
        3. Zeaxanthin
          1. Zeaxanthin By Value
      3. Antioxidants
        1. By Value
      4. Omega-3 Fatty acids
        1. By Value
      5. Coenzyme Q10
        1. By Value
      6. Flavonoids
        1. By Value
    3. By Therapeutic Targets
      1. Introduction
        1. Therapeutic Targets By Value
      2. Age-related Macular Degeneration (AMD)
        1. By Value
      3. Cataract
        1. By Value
      4. Dry Eye Syndrome
        1. By Value
      5. Inflammation
        1. By Value
    4. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Tablets
        1. By Value
      3. Capsules
        1. By Value
      4. Powder
        1. By Value
      5. Softgels
        1. By Value
      6. Liquid
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Eye Care Clinics
        1. By Value
      4. Pharmacy
        1. By Value
    6. China
      1. By Supplement Category
        1. Introduction
          1. Supplement Category By Value
        2. Carotenoids
          1. By Value
          2. Lutein
            1. Lutein By Value
          3. Zeaxanthin
            1. Zeaxanthin By Value
        3. Antioxidants
          1. By Value
        4. Omega-3 Fatty acids
          1. By Value
        5. Coenzyme Q10
          1. By Value
        6. Flavonoids
          1. By Value
      2. By Therapeutic Targets
        1. Introduction
          1. Therapeutic Targets By Value
        2. Age-related Macular Degeneration (AMD)
          1. By Value
        3. Cataract
          1. By Value
        4. Dry Eye Syndrome
          1. By Value
        5. Inflammation
          1. By Value
      3. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Tablets
          1. By Value
        3. Capsules
          1. By Value
        4. Powder
          1. By Value
        5. Softgels
          1. By Value
        6. Liquid
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Eye Care Clinics
          1. By Value
        4. Pharmacy
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
    1. Introduction
    2. By Supplement Category
      1. Introduction
        1. Supplement Category By Value
      2. Carotenoids
        1. By Value
        2. Lutein
          1. Lutein By Value
        3. Zeaxanthin
          1. Zeaxanthin By Value
      3. Antioxidants
        1. By Value
      4. Omega-3 Fatty acids
        1. By Value
      5. Coenzyme Q10
        1. By Value
      6. Flavonoids
        1. By Value
    3. By Therapeutic Targets
      1. Introduction
        1. Therapeutic Targets By Value
      2. Age-related Macular Degeneration (AMD)
        1. By Value
      3. Cataract
        1. By Value
      4. Dry Eye Syndrome
        1. By Value
      5. Inflammation
        1. By Value
    4. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Tablets
        1. By Value
      3. Capsules
        1. By Value
      4. Powder
        1. By Value
      5. Softgels
        1. By Value
      6. Liquid
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Eye Care Clinics
        1. By Value
      4. Pharmacy
        1. By Value
    6. UAE
      1. By Supplement Category
        1. Introduction
          1. Supplement Category By Value
        2. Carotenoids
          1. By Value
          2. Lutein
            1. Lutein By Value
          3. Zeaxanthin
            1. Zeaxanthin By Value
        3. Antioxidants
          1. By Value
        4. Omega-3 Fatty acids
          1. By Value
        5. Coenzyme Q10
          1. By Value
        6. Flavonoids
          1. By Value
      2. By Therapeutic Targets
        1. Introduction
          1. Therapeutic Targets By Value
        2. Age-related Macular Degeneration (AMD)
          1. By Value
        3. Cataract
          1. By Value
        4. Dry Eye Syndrome
          1. By Value
        5. Inflammation
          1. By Value
      3. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Tablets
          1. By Value
        3. Capsules
          1. By Value
        4. Powder
          1. By Value
        5. Softgels
          1. By Value
        6. Liquid
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Eye Care Clinics
          1. By Value
        4. Pharmacy
          1. By Value
    7. Turkey
    8. Saudi Arabia
    9. South Africa
    10. Egypt
    11. Nigeria
    12. Rest of MEA
    1. Introduction
    2. By Supplement Category
      1. Introduction
        1. Supplement Category By Value
      2. Carotenoids
        1. By Value
        2. Lutein
          1. Lutein By Value
        3. Zeaxanthin
          1. Zeaxanthin By Value
      3. Antioxidants
        1. By Value
      4. Omega-3 Fatty acids
        1. By Value
      5. Coenzyme Q10
        1. By Value
      6. Flavonoids
        1. By Value
    3. By Therapeutic Targets
      1. Introduction
        1. Therapeutic Targets By Value
      2. Age-related Macular Degeneration (AMD)
        1. By Value
      3. Cataract
        1. By Value
      4. Dry Eye Syndrome
        1. By Value
      5. Inflammation
        1. By Value
    4. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Tablets
        1. By Value
      3. Capsules
        1. By Value
      4. Powder
        1. By Value
      5. Softgels
        1. By Value
      6. Liquid
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Eye Care Clinics
        1. By Value
      4. Pharmacy
        1. By Value
    6. Brazil
      1. By Supplement Category
        1. Introduction
          1. Supplement Category By Value
        2. Carotenoids
          1. By Value
          2. Lutein
            1. Lutein By Value
          3. Zeaxanthin
            1. Zeaxanthin By Value
        3. Antioxidants
          1. By Value
        4. Omega-3 Fatty acids
          1. By Value
        5. Coenzyme Q10
          1. By Value
        6. Flavonoids
          1. By Value
      2. By Therapeutic Targets
        1. Introduction
          1. Therapeutic Targets By Value
        2. Age-related Macular Degeneration (AMD)
          1. By Value
        3. Cataract
          1. By Value
        4. Dry Eye Syndrome
          1. By Value
        5. Inflammation
          1. By Value
      3. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Tablets
          1. By Value
        3. Capsules
          1. By Value
        4. Powder
          1. By Value
        5. Softgels
          1. By Value
        6. Liquid
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Eye Care Clinics
          1. By Value
        4. Pharmacy
          1. By Value
    7. Mexico
    8. Argentina
    9. Chile
    10. Colombia
    11. Rest of LATAM
    1. Eye Health Supplements Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Biosyntrx Inc. (The U.S.)
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Nordic Naturals Inc. (The U.S.)
    3. Bristol-Myers Squibb Company (The U.S.)
    4. Healths Harmony LLC (The U.S)
    5. NUSAPURE (The U.S.)
    6. Vitabiotics Ltd. (U.K)
    7. Bausch Lomb Incorporated (The U.S.)
    8. zNatures Bounty Co. (The U.S.)
    9. Pfizer Inc.(The U.S.)
    10. Amway International(The U.S.)
    11. ZeaVision LLC(The U.S.)
    12. Kemin Industries, Inc.(The U.S.)
    13. EyeScience(The U.S.)
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
The global brain health supplements market size was valued at USD 7.60 billion in 2021 and is predicted to reach USD 15.59 billion by 2030, increasing at a CAGR of 8.31% from 2022 to 2030.  Various natural and herbal dietary ingredients are use
Buy Now
Global Report
Digestive Health Supplements Market Size The global market size for digestive health supplements was valued at USD 11 billion in 2021, and it is anticipated to reach USD 21.41 billion by 2030 at a CAGR of 8.68%.  Digestive health supp
Buy Now
Global Report
Market Overview The global pet supplements market size was valued at USD 1.89 billion in 2023. It is expected to reach USD 3.17 billion in 2032, growing at a CAGR of 5.94% over the forecast period (2024-32). Pet owners are becoming more aware of the
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.